Gefitero 250mg Tablet
  1. Home
  2. Pharma Products
  3. Hetero Healthcare Ltd
  4. Gefitero 250mg Tablet

Gefitero 250mg Tablet

Gefitero 250 mg Tablet contains gefitinib 250 mg and is an oral targeted anticancer medicine. It is used for adults with locally advanced or metastatic non-small cell lung cancer whose tumors have activating EGFR mutations. The medicine is available by prescription and should be taken under the supervision of an oncologist.

BUY NOW

Category

Gefitinib is an epidermal growth factor receptor tyrosine kinase inhibitor that blocks EGFR signaling involved in the growth and survival of certain cancer cells. It is specifically used in patients with appropriate EGFR-mutated non-small cell lung cancer according to the treating specialist’s assessment. The usual recommended dose is 250 mg once daily and it can be taken with or without food. Medical monitoring may include assessment of liver function and evaluation for adverse effects such as diarrhea, skin reactions, and respiratory symptoms.

Technical Specification

Specification Details
Active Ingredient Gefitinib
Strength 250 mg
Dosage Form Tablet
Pack Size 10 tablets
Route of Administration Oral
Manufacturer/Marketer Hetero Healthcare Ltd.

Product Also Known As

Gefitero 250mg Tablet, Gefitero 250 mg Tablet, Gefitero 250 Tablet, Gefitinib 250mg Tablet, Gefitinib 250 mg Tablet, Gefitinib Oral Tablet, Gefitinib 250mg Anticancer Tablet